Jackson Grant Investment Advisers’s Idexx Laboratories IDXX Stock Holding History

Jackson Grant Investment Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$3.19K	–	408
2025 Q3	$3.19K	Hold	5	–	–	﹤0.01%	376
2025 Q2	$2.68K	Hold	5	–	–	﹤0.01%	356
2025 Q1	$2.1K	Hold	5	–	–	﹤0.01%	359
2024 Q4	$2.07K	Hold	5	–	–	﹤0.01%	374
2024 Q3	$2.53K	Hold	5	–	–	﹤0.01%	364
2024 Q2	$2.44K	Hold	5	–	–	﹤0.01%	361
2024 Q1	$2.7K	Hold	5	–	–	﹤0.01%	344
2023 Q4	$2.77K	Hold	5	–	–	﹤0.01%	336
2023 Q3	$2.19K	Hold	5	–	–	﹤0.01%	346
2023 Q2	$2.51K	Hold	5	–	–	﹤0.01%	355
2023 Q1	$2.5K	Buy	+5	New	+$2.39K	﹤0.01%	376

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Jackson Grant Investment Advisers's IDXX Position: Q4 2025 in Review

Jackson Grant Investment Advisers sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 5 shares — an estimated $3.19K sold.

Jackson Grant Investment Advisers first reported a position in IDXX in Q1 2023 and held it in 11 quarters. The position peaked at $3.19K in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Jackson Grant Investment Advisers reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
Jackson Grant Investment Advisers sold 5 Idexx Laboratories shares in Q4 2025, an estimated $3.19K.
Jackson Grant Investment Advisers first reported a position in Idexx Laboratories in Q1 2023 and held it in 11 quarters.
Jackson Grant Investment Advisers's Idexx Laboratories position peaked at $3.19K in Q3 2025.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Jackson Grant Investment Advisers's 13F filing for Q4 2025, filed 27 Jan 2026.